Pemazyre 9 MG tabs

Ended Awarded

Contract number
36C26221F0383
Awardee
Awarding agency
Obligated
$12,725

Award facts

Contract value 100% obligated
$12,725.23 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
325412 Pharmaceutical Preparation Manufacturing
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price
Place of performance
San Diego, CA 92161, USA

Award details come from SAM.gov/FPDS.

About this award

The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 22 awarded Incyte Corporation a $12,725.23 delivery order against the Pharmaceuticals and Drugs Federal Supply Schedule contract (FSS-61-IB) for a firm fixed price. The order is for PEMAZYRE 9 MG tablets to fulfill requirements under the referenced master agreement. Performance will take place in San Diego, California with completion by July 28, 2021. No set-aside provisions were applied to this award to supply cancer treatment medications to veterans served by VISN 22 in support of the VA's healthcare mission.

Quick answers

Who was awarded contract 36C26221F0383?

36C26221F0383 was awarded to Incyte Corporation by Veterans Integrated Service Network 22 (Veterans Health Administration) on June 29, 2021.

How much is contract 36C26221F0383 worth?

The government has obligated $12,725 on 36C26221F0383.

Is contract 36C26221F0383 an order under another contract?

Yes. 36C26221F0383 is a delivery order under 36F79720D0189, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).

Was contract 36C26221F0383 competed?

The extent of competition for 36C26221F0383 was full and open competition. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award